• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Dual Checkpoint Inhibition in Pancreatic Cancer: Revealing the Limitations of Synergy and the Potential of Novel Combinations.

作者信息

Osipov Arsen, Zaidi Neeha, Laheru Dan A

机构信息

Skip Viragh Center for Pancreatic Cancer Research and Clinical Care, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.

出版信息

JAMA Oncol. 2019 Oct 1;5(10):1438-1439. doi: 10.1001/jamaoncol.2019.1583.

DOI:10.1001/jamaoncol.2019.1583
PMID:31318378
Abstract
摘要

相似文献

1
Dual Checkpoint Inhibition in Pancreatic Cancer: Revealing the Limitations of Synergy and the Potential of Novel Combinations.胰腺癌中的双重检查点抑制：揭示协同作用的局限性和新型联合疗法的潜力
JAMA Oncol. 2019 Oct 1;5(10):1438-1439. doi: 10.1001/jamaoncol.2019.1583.
2
Combination checkpoint inhibitors for treatment of non-small-cell lung cancer: an update on dual anti-CTLA-4 and anti-PD-1/PD-L1 therapies.用于治疗非小细胞肺癌的联合检查点抑制剂：双重抗CTLA-4和抗PD-1/PD-L1疗法的最新进展
Drugs Context. 2020 Jan 13;9. doi: 10.7573/dic.2019-9-2. eCollection 2020.
3
Assessment of Clinical Activity of PD-1 Checkpoint Inhibitor Combination Therapies Reported in Clinical Trials.评估临床试验中报告的 PD-1 检查点抑制剂联合治疗的临床活性。
JAMA Netw Open. 2020 Feb 5;3(2):e1920833. doi: 10.1001/jamanetworkopen.2019.20833.
4
Dual CTLA-4 and PD-L1 Blockade Inhibits Tumor Growth and Liver Metastasis in a Highly Aggressive Orthotopic Mouse Model of Colon Cancer.双重 CTLA-4 和 PD-L1 阻断抑制结直肠癌高度侵袭性原位模型中的肿瘤生长和肝转移。
Neoplasia. 2019 Sep;21(9):932-944. doi: 10.1016/j.neo.2019.07.006. Epub 2019 Aug 11.
5
Combining targeted therapy and immune checkpoint inhibitors in the treatment of metastatic melanoma.将靶向治疗与免疫检查点抑制剂联合用于转移性黑色素瘤的治疗。
Cancer Biol Med. 2014 Dec;11(4):237-46. doi: 10.7497/j.issn.2095-3941.2014.04.002.
6
Immune checkpoint therapy for pancreatic cancer.胰腺癌的免疫检查点疗法。
World J Gastroenterol. 2016 Nov 21;22(43):9457-9476. doi: 10.3748/wjg.v22.i43.9457.
7
Determination of in vitro synergy for dual antimicrobial therapy against resistant Neisseria gonorrhoeae using Etest and agar dilution.采用 Etest 和琼脂稀释法测定针对耐药淋病奈瑟菌的双重抗菌治疗的体外协同作用。
Int J Antimicrob Agents. 2015 Mar;45(3):305-8. doi: 10.1016/j.ijantimicag.2014.10.020. Epub 2014 Dec 2.
8
In silico drug combination discovery for personalized cancer therapy.用于个性化癌症治疗的计算机辅助药物组合发现
BMC Syst Biol. 2018 Mar 19;12(Suppl 2):16. doi: 10.1186/s12918-018-0546-1.
9
Inhibition of phosphorolysis catalyzed by HIV-1 reverse transcriptase is responsible for the synergy found in combinations of 3'-azido-3'-deoxythymidine with nonnucleoside inhibitors.由HIV-1逆转录酶催化的磷酸解作用受到抑制，这是在3'-叠氮-3'-脱氧胸苷与非核苷抑制剂联合使用时发现协同作用的原因。
Biochemistry. 2005 Mar 8;44(9):3535-46. doi: 10.1021/bi048129z.
10
Checkpoint inhibitors in pancreatic cancer.胰腺癌的检查点抑制剂。
Cancer Treat Rev. 2019 Aug;78:17-30. doi: 10.1016/j.ctrv.2019.06.005. Epub 2019 Jun 27.

引用本文的文献

1
Emerging immunological strategies: recent advances and future directions.新兴免疫策略：最新进展与未来方向。
Front Med. 2021 Dec;15(6):805-828. doi: 10.1007/s11684-021-0886-x. Epub 2021 Dec 6.
2
DPP inhibition alters the CXCR3 axis and enhances NK and CD8+ T cell infiltration to improve anti-PD1 efficacy in murine models of pancreatic ductal adenocarcinoma.DPP 抑制改变了 CXCR3 轴，增强了自然杀伤细胞和 CD8+T 细胞浸润，从而提高了胰腺导管腺癌小鼠模型中抗 PD-1 的疗效。
J Immunother Cancer. 2021 Nov;9(11). doi: 10.1136/jitc-2021-002837.
3
Development of bispecific antibodies in China: overview and prospects.
中国双特异性抗体的发展：概述与展望
Antib Ther. 2020 May 30;3(2):126-145. doi: 10.1093/abt/tbaa011. eCollection 2020 Apr.
4
Management of Non-Colorectal Digestive Cancers with Microsatellite Instability.微卫星不稳定的非结直肠癌的管理
Cancers (Basel). 2021 Feb 6;13(4):651. doi: 10.3390/cancers13040651.
5
Vaccine-Induced Intratumoral Lymphoid Aggregates Correlate with Survival Following Treatment with a Neoadjuvant and Adjuvant Vaccine in Patients with Resectable Pancreatic Adenocarcinoma.疫苗诱导的肿瘤内淋巴聚集与可切除胰腺腺癌患者新辅助和辅助疫苗治疗后的生存相关。
Clin Cancer Res. 2021 Mar 1;27(5):1278-1286. doi: 10.1158/1078-0432.CCR-20-2974. Epub 2020 Dec 4.
6
Role of in silico structural modeling in predicting immunogenic neoepitopes for cancer vaccine development.基于计算机的结构建模在预测癌症疫苗开发的免疫原性新表位中的作用。
JCI Insight. 2020 Sep 3;5(17):136991. doi: 10.1172/jci.insight.136991.
7
Immunologic alterations in the pancreatic cancer microenvironment of patients treated with neoadjuvant chemotherapy and radiotherapy.新辅助化疗和放疗治疗的胰腺癌患者微环境中的免疫改变。
JCI Insight. 2020 Jan 16;5(1):130362. doi: 10.1172/jci.insight.130362.